首页>
外国专利>
Genu stage no processes for the assessment of risk for the occurrence of glaucoma
Genu stage no processes for the assessment of risk for the occurrence of glaucoma
展开▼
机译:Genu阶段没有评估青光眼发生风险的程序
展开▼
页面导航
摘要
著录项
相似文献
摘要
To provide a gene examination method for predicting the onset risk of glaucoma based on the relation between a glaucoma-associated gene and the onset of glaucoma, the onset of glaucoma in future is predicted by using as an indication mutations in the gene region involving the code region and/or the upstream region of a glaucoma-associated gene. In the base sequence represented by SEQ ID NO:1, mutation(s) in at least one of the following positions are detected, i.e., the 194-, 199-, 324-, 1051-, 1084-, 1627-, 1685-, 1756-, 1853-, 2830-, 3371-, 4037- and 4364-positions.
展开▼
机译:为了提供一种基于青光眼相关基因与青光眼发作之间的关系来预测青光眼发作风险的基因检查方法,通过将涉及该密码子的基因区域中的突变用作指示来预测将来的青光眼发作青光眼相关基因的区域和/或上游区域。在由SEQ ID NO:1表示的碱基序列中,检测到以下至少一个位置的突变,即194-,199-,324-,1051-,1084-,1627-,1685-。 ,1756-,1853-,2830-,3371、4037-和4364-位置。
展开▼